Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Clinical trial NCT02069145 · COMPLETED
Trial details
- NCT number
- NCT02069145
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2017-05-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.